capsovision.com (CV) Forward P/S Multiple

Brandmark of CapsoVision (CV)

The implementation of smart video capsules, which have replaced invasive gastrointestinal examinations, is driving the price action for CapsoVision Inc (CV). The forward price-to-sales ratio visualizes this trend, where 22.60 captures the magnitude of this parameter. The business foundation rests on the CapsoCam patent, which ensures patient comfort during examinations, while the high technological complexity of omnidirectional wireless endoscopes securely protects the company's market position.

CapsoVision, Inc. - CV Forward P/S Multiple (period 07/03/2025 - 11/13/2026)

Comprehensive metric breakdowns and analytics for capsovision.com (CV)

- current price and projected stock value:
Stock Price CapsoVision|CV - Analyst Median Target
- market capitalization details:
Market Capitalization CV|CV - Real Price to Acquire Entire Company
- issuer book value statistics:
Book Value per Share CapsoVision Inc|CV - Book Capitalization|Market Value to Book Value Ratio capsovision.com|CV - Aggregate Company Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio CapsoVision Inc|CV - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital CapsoVision|CV - Company Cumulative Debt|Debt to Book Capitalization Ratio CV|CV - Long-Term Indebtedness|Company Current Liabilities CapsoVision Inc|Quick Ratio capsovision.com
- financial results and valuation multiples details:
CV - Net Financial Result|Expected Profit CapsoVision Inc|CV - Market Cap to Net Income|Future Price to Earnings CapsoVision|CV - Price/Earnings to Growth Multiple|EV/EBITDA Multiple CV|CV - Profit before interest, taxes and amortization|Earnings per share for the last twelve months CapsoVision Inc|CV - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months capsovision.com|CV - Net earnings per one share growth for the current year|Earnings growth forecast for next year CapsoVision Inc
- total revenue and sales volume data:
CV - Company Sales|Projected Sales Volume CapsoVision|CV - P/S Multiple|Price-to-Projected Revenue Ratio CV
Initial company analysis:CV (CapsoVision Medical)
Manufactured products of capsovision.com

For CapsoVision Inc (CV), the efficiency of the gentle express delivery of fragile endoscopes to clinics directly impacts revenue growth rates, making the analysis of future sales a key tool for capital preservation. The ratio of market value to expected turnover, reflected in the projected price-to-sales capitalization, allows for an assessment of current multiples and determines the degree to which the asset is overbought relative to its fundamental prospects.

Main competitors

Forward P/S Multiple ABT (Abbott)|Market Cap to Expected Sales Ratio Thermo Fisher Scientific Inc. (TMO)|GE Healthcare Corp - Forward P/S Multiple|Mettler Toledo Inc (MTD) - Forward Price-to-Revenue Multiple|WAT: Forward P/S Multiple|bio-techne.com (TECH) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Bruker|Price-to-Projected Revenue Ratio AZTA|Forward Price-to-Revenue Multiple VREX (Varex)|SMLR (Semler) - Forward Price to Sales|Forward P/S Multiple BFLY (Butterfly Network, Inc.)|mesalabs.com (MLAB) - Market Cap to Future Revenue Ratio|QSI - Price-to-Projected Revenue Ratio|Projected Price to Revenue Nano-X Imaging (NNOX)|QTRX (Quanterix Corp) - Forward Price-to-Revenue Multiple|908 Devices Corporation (MASS) - Forward P/S Multiple|MXCT (MaxCyte, Inc.) - Forward P/S Multiple|Rapid Micro (RPID) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Seer (SEER)|HYPR: Future Price to Revenue|Price-to-Projected Revenue Ratio FONAR Corp FONR|DXR - Forward Price-to-Revenue Multiple|Spectral AI - Forward P/S Multiple|Market Cap to Future Revenue Ratio VivoSim Labs|Aclarion, Inc. (ACON) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue AKYA|Forward Price-to-Revenue Multiple THMO|TLIS (Talis Biomedical Corp) - Price to Expected Revenue Ratio|Forward P/S Multiple TTOO